BLOOD

AuthorsKarthik Chetlapalli; Satoko Ito; Ding Quan Ng; Manraj Sra; Daniel Wang; Harlan M. Krumholz; Lakshmanan Krishnamurti; Ankur Pandya; George Goshua

Affiliations1. 1Yale School of Medicine, New Haven, CT; 2. 2Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT; 3. 3Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; 4. 4Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; 5. 5Yale Center for Outcomes Research and Evaluation, Yale New Haven Hospital and Yale University, New Haven, CT; 6. 6Section of Pediatric Hematology, Oncology and Bone Marrow Transplant, Yale School of Medicine, New Haven, CT; 7. 7Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA

AuthorsJohanna M. Horns; Thomas Beder; Axel Künstner; Malwine J. Barz; Sonja Bendig; Cecilia Bozzetti; Guranda Chitadze; Nikos Darzentas; Katharina Iben; Michaela Kotrova; José I. Martín-Subero; Mayukh Mondal; Martin Neumann; Raúl F. Pérez; Aeint-Steffen Ströh; Wiebke Weßels; Lennart Lenk; Lars Velten; Boris Böll; Krischan Braitsch; Veit Bücklein; Johannes Duell; Christoph Faul; Walter Fiedler; Maher Hanoun; Snjezana Janjetovic; Felix Klingler; Stefan Knop; Christoph Röllig; Stefan Schwartz; Bernd Spriewald; Björn Steffen; Klaus Wethmar; Hauke Busch; Nicola Gökbuget; Claudia D. Baldus; Lorenz Bastian; Monika Brüggemann

Affiliations1. 1Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; 2. 2Clinical Research Unit CATCH ALL (KFO 5010) Kiel, Germany; 3. 3Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany; 4. 4Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; 5. 5Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain; 6. 6Departament de Fonaments Clínics, University of Barcelona, Barcelona, Spain; 7. 7Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; 8. 8Institute for Clinical Molecular Biology, Christian-Albrechts-University Kiel, Kiel, Germany; 9. 9Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Complutense University of Madrid, Madrid, Spain; 10. 10Department of Pediatrics I, University Hospital Schleswig-Holstein, Kiel, Germany; 11. 11Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain; 12. 12Universitat Pompeu Fabra, Barcelona, Spain; 13. 13Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; 14. 14Department of Medicine III, TUM University Hospital, Technical University of Munich, Munich, Germany; 15. 15Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany; 16. 16Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany; 17. 17Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany; 18. 18Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 19. 19Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany; 20. 20Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany; 21. 21Department of Hematology and Oncology, Nuremberg General Hospital, Nuremberg, Germany; 22. 22Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany; 23. 23Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité– Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany; 24. 24German Cancer Consortium, partner site Berlin, a partnership between German Cancer Research Center and Charité – Universitätsmedizin Berlin, Berlin, Germany; 25. 25Department of Internal Medicine 5 - Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinik Erlangen, Erlangen, Germany; 26. 26Department of Medicine II, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany; 27. 27Department of Medicine A, Hematology, Oncology, Hemostaseology and Pneumology, University Hospital Münster, Münster, Germany

AuthorsChang Xu; Xue Lv; Shangda Yang; Yanling Lv; Yawei Zheng; Yu-xiang Wang; Yan Hui; Guohuan Sun; Xiangnan Zhao; Lan-yue Ma; Honglin Duan; Linmin Zhang; Shuangshuang Pu; Lu Sun; Xialin Li; Yicheng He; Wenjia Fang; Meng Yang; Toshio Suda; Qi Chen; Tao Cheng; Hui Cheng

Affiliations1. 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; 2. 2Tianjin Institutes of Health Science, Tianjin, China; 3. 3Department of Stem Cell & Regenerative Medicine, Peking Union Medical College, Tianjin, China; 4. 4Center for Cell Lineage and Development, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

AuthorsMariam Hakobyan; Jens Langstein; María José Ramos Medina; Emely Kleinert; Maximilian Schönung; Mark Hartmann; Hannah Rohdjess; Jessica Wojtarowicz; Sina Staeble; Melissa Türe; Yasmine Pobiedonoscew; Rainer Claus; Lars Bullinger; Christopher C. Oakes; Katharina Zoldan; Michael Cross; Uwe Platzbecker; Niclas Kneisel; Simon Raffel; Ulrich Germing; Gregor Hoermann; Simon Haas; Karsten Rippe; Stefan Fröhling; Stefan Pusch; Christoph Plass; Michael D. Milsom; Daniel B. Lipka

Affiliations1. 1Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany; 2. 2National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany; 3. 3Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; 4. 4Division of Experimental Hematology, German Cancer Research Center, Heidelberg, Germany; 5. 5Personalized Tumor Medicine and Molecular Oncology, University Hospital Augsburg, Augsburg, Germany; 6. 6Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 7. 7Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH; 8. 8Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany; 9. 9Servier Germany GmbH, Munich, Germany; 10. 10Department of Medicine, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany; 11. 11Department of Hematology, Oncology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany; 12. 12MLL Munich Leukemia Laboratory, Munich, Germany; 13. 13Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany; 14. 14Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; 15. 15Precision Healthcare University Research Institute, Queen Mary University of London, London, United Kingdom; 16. 16German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany; 17. 17Division of Chromatin Networks, German Cancer Research Center and BioQuant, Heidelberg, Germany; 18. 18Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany; 19. 19Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; 20. 20Clinical Cooperation Unit Neuropathology, German Cancer Research Consortium, German Cancer Research Center, Heidelberg, Germany; 21. 21Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany; 22. 22Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany; 23. 23The Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany; 24. 24Faculty of Medicine, Otto von Guericke University, Magdeburg, Germany

AuthorsEmma M. Groarke; Fernanda Gutierrez-Rodrigues; Bhavisha A. Patel

Affiliations1. Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD